R&D,Biomanufacturing,Clinical Operations,Weekly Roundups,Biology

Weekly News Round-up – 1/4/21

3 years ago By Charlotte Di Salvo

In the news this week, GSK agrees to support NOVAVAX vaccine production to meet UK targets. In other news, Amgen Inc. confirms its agreement to acquire Rodeo Therapeutics, and COVID-19 vaccine production is boosted by expansions in production with BioNtech and Pfizer. 

GSK SUPPORTS NOVAVAX COVID 19 VACCINE MANUFACTURING – In collaboration with NOVAVAX and the UK’s Vaccines Task Force, GSK has agreed to support the manufacturing of up to 60 million COVID-19 vaccines. The recent partnership could increase production capacity and meet the April 15 deadline to offer a first dose to all over 50’s. 

AMGEN TO ACQUIRE RODEO THERAPEUTICS – Under a new agreement, Amgen Inc. will acquire Rodeo Therapeutics Corporation. The strategic move by Amgen seeks to collaborate with Rodeo’s enzyme programme (15-PGDH) to develop ‘first-in-class’ therapeutics alongside Amgen’s inflammation research. Any outstanding shares of Rodeo will be acquired by Amgen in exchange for an upfront payment of $55 million. 

2021 VACCINE TARGET BOOSTED BY BIONTECH-PFIZER – With further manufacturing capacity, expansion BioNTech and Pfizer could deliver 2.5 billion COVID-19 doses by 2022. The recent addition of BioNTech’s latest facility in Marburg, Germany, has resulted in expansion of the manufacturing and supply network to accelerate commercial production. 

R&D
IBM unveils next steps in AI technology with quantum computer

Clinical
First cell-based gene therapy approved for Adult Multiple Myeloma by FDA

Manufacturing 
Human error costs J&J 15 million COVID-19 vaccines

That’s all for now. See you next week!

Charlotte Di Salvo, Junior Medical Writer
Proventa International

More news

Navigating the Complex World of Global Regulatory Affairs in Oncology

In today's fast-paced global pharmaceutical landscape, the regulatory affairs sector plays a pivotal role in ensuring the safety, efficacy, and market access of oncology drugs. As the demand for innovative cancer therapies continues to grow, understanding the intricacies of global...

7 months ago
R&D,Biomanufacturing,Clinical Operations,Weekly Roundups,Biology

Navigating the Complex World of Global Regulatory Affairs in Oncology

In today's fast-paced global pharmaceutical landscape, the regulatory affairs sector plays a pivotal role in ensuring the safety, efficacy, and market access of oncology drugs. As the demand for innovative cancer therapies continues to grow, understanding the intricacies of global...

7 months ago

Overcoming the Hurdles: Navigating the Challenges in Oncology Clinical Trials

In the world of medical research, oncology clinical trials are at the forefront of innovation and discovery. These trials play a crucial role in advancing our understanding of cancer and developing more effective treatments. However, the path to successful oncology...

7 months ago
R&D,Biomanufacturing,Clinical Operations,Weekly Roundups,Biology

Overcoming the Hurdles: Navigating the Challenges in Oncology Clinical Trials

In the world of medical research, oncology clinical trials are at the forefront of innovation and discovery. These trials play a crucial role in advancing our understanding of cancer and developing more effective treatments. However, the path to successful oncology...

7 months ago

Embracing a Patient-Centric Approach in Oncology Trials

In the realm of healthcare and medical research, the term "patient-centric" has gained significant traction in recent years. This shift in focus towards prioritizing patients' needs and preferences is not only transforming the healthcare industry but is also making waves...

7 months ago
R&D,Biomanufacturing,Clinical Operations,Weekly Roundups,Biology

Embracing a Patient-Centric Approach in Oncology Trials

In the realm of healthcare and medical research, the term "patient-centric" has gained significant traction in recent years. This shift in focus towards prioritizing patients' needs and preferences is not only transforming the healthcare industry but is also making waves...

7 months ago